ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 122 filers reported holding ANAPTYSBIO INC in Q3 2019. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $42,316,000 | -38.0% | 1,209,378 | 0.0% | 0.01% | -37.5% |
| Q2 2019 | $68,233,000 | +7.5% | 1,209,378 | +39.2% | 0.02% | +6.7% |
| Q1 2019 | $63,444,000 | +14.5% | 868,500 | 0.0% | 0.02% | 0.0% |
| Q4 2018 | $55,402,000 | -29.2% | 868,500 | +10.7% | 0.02% | -21.1% |
| Q3 2018 | $78,270,000 | +184.7% | 784,500 | +102.7% | 0.02% | +216.7% |
| Q2 2018 | $27,492,000 | -13.1% | 387,000 | +27.3% | 0.01% | -14.3% |
| Q1 2018 | $31,640,000 | – | 304,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $53,362,000 | 8.10% |
| EcoR1 Capital, LLC | 7,521,024 | $152,677,000 | 5.27% |
| GREAT POINT PARTNERS LLC | 453,118 | $9,198,000 | 2.21% |
| Soleus Capital Management, L.P. | 643,575 | $13,065,000 | 2.04% |
| Frazier Life Sciences Management, L.P. | 899,700 | $18,264,000 | 1.72% |
| Boxer Capital, LLC | 1,300,000 | $26,390,000 | 1.67% |
| Deep Track Capital, LP | 672,569 | $13,653,000 | 0.90% |
| Palo Alto Investors LP | 431,024 | $8,750,000 | 0.76% |
| TCG Crossover Management, LLC | 58,515 | $1,188,000 | 0.50% |
| HighVista Strategies LLC | 33,103 | $672,000 | 0.41% |